Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 3
1967 1
1968 3
1970 3
1971 3
1974 2
1975 2
1976 1
1979 3
1980 1
1981 1
1982 2
1983 1
1985 1
1988 2
1989 5
1990 5
1991 2
1992 5
1993 3
1994 3
1995 6
1996 8
1997 3
1998 5
1999 6
2000 7
2001 8
2002 2
2003 7
2004 6
2005 6
2006 5
2007 3
2008 6
2009 14
2010 9
2011 11
2012 16
2013 12
2014 15
2015 15
2016 15
2017 12
2018 14
2019 19
2020 27
2021 36
2022 30
2023 12
2024 16
2025 29
2026 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

393 results

Results by year

Filters applied: . Clear all
Page 1
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.
Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hollaender N, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F; REACH3 Investigators. Zeiser R, et al. Among authors: musso m. N Engl J Med. 2021 Jul 15;385(3):228-238. doi: 10.1056/NEJMoa2033122. N Engl J Med. 2021. PMID: 34260836 Clinical Trial.
Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study.
Zeiser R, Russo D, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hamad N, Burock K, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F. Zeiser R, et al. Among authors: musso m. J Clin Oncol. 2025 Aug 10;43(23):2566-2571. doi: 10.1200/JCO-24-02477. Epub 2025 Jun 25. J Clin Oncol. 2025. PMID: 40561385 Free PMC article. Clinical Trial.
Failing Families.
Musso M. Musso M. Acad Psychiatry. 2023 Dec;47(6):597-598. doi: 10.1007/s40596-023-01886-3. Epub 2023 Oct 11. Acad Psychiatry. 2023. PMID: 37821716 No abstract available.
Residents Need Recess.
Musso MW, Woodward C, Crapanzano K, Bolton M, Roy M, Caffery TS. Musso MW, et al. AEM Educ Train. 2020 Aug 17;5(3):e10514. doi: 10.1002/aet2.10514. eCollection 2021 Jul. AEM Educ Train. 2020. PMID: 34027279 Free PMC article. No abstract available.
Real-world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study.
Lucchini E, Vianelli N, Consoli U, Carli G, Carrai V, Carpenedo M, De Stefano V, Gaidano G, Palandri F, Auteri G, Rossi E, Patriarca A, Innao V, Marchesini G, Ballerini M, Rossetti MC, Mosini G, Sciancalepore P, Agnelli Giacchello J, Musto P, Rivolti E, Soverini G, Borchiellini A, Clissa C, Pane F, Galimberti S, Pavone V, Poloni A, Buccisano F, Musso M, Fazi P, Paoloni F, Gorreo Renzulli L, Zaja F. Lucchini E, et al. Among authors: musso m. Br J Haematol. 2025 Dec;207(6):2529-2538. doi: 10.1111/bjh.70069. Epub 2025 Aug 25. Br J Haematol. 2025. PMID: 40855761
Gilteritinib in FLT3-mutated acute myeloid leukemia: A real-world Italian experience.
Cairoli R, Del Castello L, Imbergamo S, Pierdomenico E, Papayannidis C, Borlenghi E, Vetro C, Chiusolo P, Fumagalli M, Minotti C, Marchesi F, Bernardi M, Musto P, Fracchiolla N, Candoni A, Lunghi M, Musso M, Guolo F, Mannina D, Lico A, Scattolin AM, Crugnola M, Galimberti S, Nadali G, Turrini M, Zappasodi P, Todisco E, Basilico C, Grillo G, Mancini V, Riva M, Bernasconi DP, Greco R. Cairoli R, et al. Among authors: musso m. Cancer. 2025 Sep 1;131(17):e70055. doi: 10.1002/cncr.70055. Cancer. 2025. PMID: 40839405 Free PMC article.
Déprescription et santé durable : enseignements d’une journée interdisciplinaire.
Brunn M, Nouguez É, Stahl E, Cocard M, Berna F, Bouglé C, Bouquet S, Bounoure F, Cabelguenne D, Castel P, Chirac P, Dariel O, Depoux A, Duprat L, Gigon E, Fournier JP, Halpern C, Huon JF, Kelley S, Laforest-Bruneaux A, Leneel H, Le Quinio P, Masia C, Musso M, Or Z, Planel MP, Santucci R, Senn N, Thierry JP, Traon C. Brunn M, et al. Among authors: musso m. Sante Publique. 2026;38(2):153-159. doi: 10.3917/spub.262.0153. Sante Publique. 2026. PMID: 42168089 French.
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study.
Polverelli N, Zerbi C, Benevento MG, Algeri M, Algarotti A, Angelucci E, Balduzzi AC, Basiricò M, Bassi S, Battipaglia G, Benedetti E, Biffi A, Bonifazi F, Borghero C, Bramanti S, Brunello L, Bresciani P, Busca A, Cairoli R, Carluccio P, Carobolante F, Carella AM, Cavattoni IM, Cerretti R, Chiappella A, Chiusolo P, Cimminiello M, Corradini P, Crescimanno A, Cuoghi A, Di Renzo N, Fagioli F, Fanin R, Faraci M, Federico V, Geromin A, Giaccone L, Giacomazzi A, Grassi A, Grillo G, Imovilli A, Ingrosso C, Iori AP, La Nasa G, Leotta S, Lupo Stanghellini MT, Mancini G, Mariotti J, Mele A, Menconi M, Merli F, Mordini N, Musso M, Nozzoli C, Pane F, Parma M, Pastano R, Pastore D, Patriarca F, Picardi A, Piemontese S, Pierini A, Piras E, Porta F, Porto G, Prete A, Prezioso L, Proia A, Raiola A, Ricci R, Roberto M, Rosignoli C, Russo D, Salvatore D, Santarone S, Saporiti G, Saraceni F, Selleri C, Serio B, Skert C, Sica S, Spina A, Tambaro FP, Tecchio C, Terruzzi E, Tumino M, Vallisa D, Zallio F, Zecca M, Taurino A, Bianchessi A, Defrancesco I, Losi G, Degrandi E, Malagola M, Castagna L, Martino M. Polverelli N, et al. Among authors: musso m. Am J Hematol. 2026 Feb;101(2):350-355. doi: 10.1002/ajh.70145. Epub 2025 Nov 25. Am J Hematol. 2026. PMID: 41292154
Rethinking the feasibility and safety of venetoclaxobinutuzumab in chronic lymphocytic leukemia: nontraditional factors may play a role in clinical practice.
Frustaci AM, Galitzia A, Lucignano M, Appio L, Olivieri J, Sanna A, Baraté C, Pane F, Schiattone L, Casadei B, Ferrarini I, Figuera A, Sportoletti P, Loseto G, Stelitano C, Visentin A, Celli M, Mauro FR, Palombi M, Coscia M, Innao V, Moia R, Motta M, Russo F, Tani M, Arcari A, Boccellato E, Borella C, Capochiani E, Ferrari A, Gentile M, Giachetti R, Giordano A, Bullo M, Lista E, Malandruccolo L, Musso M, Varettoni M, Vozella F, Cibien F, Merli M, Nocilli L, Pasquini MC, Romeo AA, Rossi V, Turri G, Vanazzi A, Cavaliere M, Gozzetti A, Crucitti L, Lucesole M, Deodato M, Tomasso A, Zappaterra A, Murru R, Patti C, Laurenti L, Tedeschi A. Frustaci AM, et al. Among authors: musso m. Haematologica. 2026 Jan 1;111(1):206-218. doi: 10.3324/haematol.2025.287799. Epub 2025 Jun 26. Haematologica. 2026. PMID: 40568727 Free PMC article.
Clinical Impact of Graft Cryopreservation on Allogeneic Stem Cell Transplantation: An Italian, Registry-Based Study on Behalf of the "Gruppo Italiano Per Il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare" (GITMO).
Defrancesco I, Ferretti VV, Chiusolo P, Russo D, Nozzoli C, Olivieri A, Gambella M, Cavattoni IM, Bramanti S, Santarone S, Fanin R, Cairoli R, Piemontese S, Parma M, Onida F, Busca A, Castagna L, Cuoghi A, Pastore D, Mordini N, Benedetti F, Skert C, Borghero C, Iori AP, Fagioli F, Pavone V, Selleri C, Cesaro S, Musso M, Ladetto M, Vallisa D, Carluccio P, Picardi A, Tozzi M, Biffi A, Milone G, Faraci M, Prete A, Prezioso L, Risitano AM, Tambaro FP, Tintori V, Galieni P, Pane F, Zerbi C, Bianchessi A, Losi G, Romano F, Taurino A, Oldani E, Polverelli N, Bonifazi F, Martino M. Defrancesco I, et al. Among authors: musso m. Am J Hematol. 2025 Aug;100(8):1354-1364. doi: 10.1002/ajh.27731. Epub 2025 Jun 2. Am J Hematol. 2025. PMID: 40456127 Free PMC article.
393 results